FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer

Tímea Tokés, László Torgyík, J. Kulka, Katalin Borka, A. Szász, Andrea Tóth, László Harsányi, Z. Lengyel, Tamás Györke, Magdolna Dank

Research output: Contribution to journalArticle

Abstract

Primary systemic therapy (PST) is a standard treatment for patients with locally advanced breast cancer. We report one of our patients to demonstrate the optimal use of FDG-PET-CT in the routine clinical workup during PST, especially when clinicians face contradictory clinical and pathological findings, and to show the advantages of this imaging modality in the decision-making process about the initial treatment choice. By reviewing the literature we would also like to confirm that FDG-PET-CT is highly sensitive in the measurement of the early therapeutic response and the prediction of the complete pathological remission, as early as after the first cycle of chemotherapy is administered.

Original languageEnglish
Pages (from-to)306-312
Number of pages7
JournalCentral European Journal of Medicine
Volume9
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Breast Neoplasms
Therapeutics
Decision Making
Positron Emission Tomography Computed Tomography
Drug Therapy

Keywords

  • Breast cancer
  • FDG-PET-CT
  • Interim
  • Ki-67
  • Primary systemic therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer. / Tokés, Tímea; Torgyík, László; Kulka, J.; Borka, Katalin; Szász, A.; Tóth, Andrea; Harsányi, László; Lengyel, Z.; Györke, Tamás; Dank, Magdolna.

In: Central European Journal of Medicine, Vol. 9, No. 2, 2014, p. 306-312.

Research output: Contribution to journalArticle

Tokés, Tímea ; Torgyík, László ; Kulka, J. ; Borka, Katalin ; Szász, A. ; Tóth, Andrea ; Harsányi, László ; Lengyel, Z. ; Györke, Tamás ; Dank, Magdolna. / FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer. In: Central European Journal of Medicine. 2014 ; Vol. 9, No. 2. pp. 306-312.
@article{1fdf682c5e224a8587c634472485bb69,
title = "FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer",
abstract = "Primary systemic therapy (PST) is a standard treatment for patients with locally advanced breast cancer. We report one of our patients to demonstrate the optimal use of FDG-PET-CT in the routine clinical workup during PST, especially when clinicians face contradictory clinical and pathological findings, and to show the advantages of this imaging modality in the decision-making process about the initial treatment choice. By reviewing the literature we would also like to confirm that FDG-PET-CT is highly sensitive in the measurement of the early therapeutic response and the prediction of the complete pathological remission, as early as after the first cycle of chemotherapy is administered.",
keywords = "Breast cancer, FDG-PET-CT, Interim, Ki-67, Primary systemic therapy",
author = "T{\'i}mea Tok{\'e}s and L{\'a}szl{\'o} Torgy{\'i}k and J. Kulka and Katalin Borka and A. Sz{\'a}sz and Andrea T{\'o}th and L{\'a}szl{\'o} Hars{\'a}nyi and Z. Lengyel and Tam{\'a}s Gy{\"o}rke and Magdolna Dank",
year = "2014",
doi = "10.2478/s11536-013-0268-0",
language = "English",
volume = "9",
pages = "306--312",
journal = "Central European Journal of Medicine",
issn = "1895-1058",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer

AU - Tokés, Tímea

AU - Torgyík, László

AU - Kulka, J.

AU - Borka, Katalin

AU - Szász, A.

AU - Tóth, Andrea

AU - Harsányi, László

AU - Lengyel, Z.

AU - Györke, Tamás

AU - Dank, Magdolna

PY - 2014

Y1 - 2014

N2 - Primary systemic therapy (PST) is a standard treatment for patients with locally advanced breast cancer. We report one of our patients to demonstrate the optimal use of FDG-PET-CT in the routine clinical workup during PST, especially when clinicians face contradictory clinical and pathological findings, and to show the advantages of this imaging modality in the decision-making process about the initial treatment choice. By reviewing the literature we would also like to confirm that FDG-PET-CT is highly sensitive in the measurement of the early therapeutic response and the prediction of the complete pathological remission, as early as after the first cycle of chemotherapy is administered.

AB - Primary systemic therapy (PST) is a standard treatment for patients with locally advanced breast cancer. We report one of our patients to demonstrate the optimal use of FDG-PET-CT in the routine clinical workup during PST, especially when clinicians face contradictory clinical and pathological findings, and to show the advantages of this imaging modality in the decision-making process about the initial treatment choice. By reviewing the literature we would also like to confirm that FDG-PET-CT is highly sensitive in the measurement of the early therapeutic response and the prediction of the complete pathological remission, as early as after the first cycle of chemotherapy is administered.

KW - Breast cancer

KW - FDG-PET-CT

KW - Interim

KW - Ki-67

KW - Primary systemic therapy

UR - http://www.scopus.com/inward/record.url?scp=84894695683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894695683&partnerID=8YFLogxK

U2 - 10.2478/s11536-013-0268-0

DO - 10.2478/s11536-013-0268-0

M3 - Article

AN - SCOPUS:84894695683

VL - 9

SP - 306

EP - 312

JO - Central European Journal of Medicine

JF - Central European Journal of Medicine

SN - 1895-1058

IS - 2

ER -